A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Sclerosing Cholangitis (PSC)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
The purpose of this clinical research study is to learn more about the use of the study medicine, volixibat, for the treatment of pruritus (itching) associated with Primary Sclerosing Cholangitis (PSC), and to assess the possible impact on the disease progression of PSC.
Epistemonikos ID: a915dbe7c92b83763c7250da93db337f976f7a4a
First added on: May 08, 2024